We are live on
!
Find out more
Invesco Pharmaceuticals ETF
PJP
PJP
71 hedge funds and large institutions have $240M invested in Invesco Pharmaceuticals ETF in 2013 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 29 increasing their positions, 20 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
45% more repeat investments, than reductions
Existing positions increased: 29 | Existing positions reduced: 20
44% more first-time investments, than exits
New positions opened: 13 | Existing positions closed: 9
32% more capital invested
Capital invested by funds: $181M → $240M (+$58.2M)
3% more funds holding
Funds holding: 69 → 71 (+2)
0.73% less ownership
Funds ownership: 26.42% → 25.68% (-0.73%)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
71
Holders Change
+2
Holders Change %
+2.9%
% of All Funds
2.06%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.03%
New
13
Increased
29
Reduced
20
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$14.6M |
| 2 |
SCM
Summit Capital Management
Seattle,
Washington
|
+$6.44M |
| 3 |
U
UBS
Zurich,
Switzerland
|
+$3.92M |
| 4 |
FAAS
First Allied Advisory Services
San Diego,
California
|
+$3.43M |
| 5 |
Morgan Stanley
New York
|
+$2.97M |
